CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
47.80
1.77%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.15
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Vericel Corp ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 48.66
Open* 48.19
1-Year Change* 56.92%
Day's Range* 47.04 - 48.76
52 wk Range 26.88-39.90
Average Volume (10 days) 1.14M
Average Volume (3 months) 9.63M
Market Cap 1.87B
P/E Ratio -100.00K
Shares Outstanding 47.72M
Revenue 185.21M
EPS -0.22
Dividend (Yield %) N/A
Beta 1.69
Next Earnings Date Feb 21, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 12, 2024 47.80 -0.15 -0.31% 47.95 48.78 46.87
Apr 11, 2024 48.66 -0.51 -1.04% 49.17 49.66 48.36
Apr 10, 2024 49.09 0.36 0.74% 48.73 49.67 47.95
Apr 9, 2024 50.25 0.13 0.26% 50.12 50.36 48.87
Apr 8, 2024 50.12 -1.17 -2.28% 51.29 51.29 50.11
Apr 5, 2024 51.00 1.05 2.10% 49.95 51.58 49.25
Apr 4, 2024 50.32 -1.00 -1.95% 51.32 51.75 50.18
Apr 3, 2024 51.22 1.03 2.05% 50.19 52.09 50.18
Apr 2, 2024 51.18 -1.04 -1.99% 52.22 52.22 51.13
Apr 1, 2024 52.82 0.87 1.67% 51.95 52.92 51.48
Mar 28, 2024 51.95 0.00 0.00% 51.95 52.37 51.45
Mar 27, 2024 52.21 2.04 4.07% 50.17 52.35 50.17
Mar 26, 2024 49.51 1.48 3.08% 48.03 49.57 48.03
Mar 25, 2024 47.81 0.81 1.72% 47.00 48.16 46.90
Mar 22, 2024 46.84 0.46 0.99% 46.38 47.23 45.72
Mar 21, 2024 46.64 0.88 1.92% 45.76 46.86 45.71
Mar 20, 2024 45.70 0.76 1.69% 44.94 45.95 44.33
Mar 19, 2024 45.57 2.01 4.61% 43.56 45.63 43.56
Mar 18, 2024 44.14 0.18 0.41% 43.96 44.49 43.30
Mar 15, 2024 44.20 0.41 0.94% 43.79 44.85 43.56

Vericel Corp Ord Events

Time (UTC) Country Event
Wednesday, May 1, 2024

Time (UTC)

13:00

Country

US

Event

Vericel Corp Annual Shareholders Meeting
Vericel Corp Annual Shareholders Meeting

Forecast

-

Previous

-
Thursday, May 2, 2024

Time (UTC)

13:00

Country

US

Event

Vericel Corp Annual Shareholders Meeting
Vericel Corp Annual Shareholders Meeting

Forecast

-

Previous

-
Wednesday, May 8, 2024

Time (UTC)

12:30

Country

US

Event

Q1 2024 Vericel Corp Earnings Release
Q1 2024 Vericel Corp Earnings Release

Forecast

-

Previous

-
Wednesday, July 31, 2024

Time (UTC)

12:30

Country

US

Event

Q2 2024 Vericel Corp Earnings Release
Q2 2024 Vericel Corp Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 164.365 156.184 124.179 117.85 90.857
Revenue 164.365 156.184 124.179 117.85 90.857
Cost of Revenue, Total 54.577 50.159 39.951 37.571 32.16
Gross Profit 109.788 106.025 84.228 80.279 58.697
Total Operating Expense 181.423 164.038 121.807 129.101 95.604
Selling/General/Admin. Expenses, Total 106.903 97.592 68.836 61.139 49.007
Research & Development 19.943 16.287 13.02 30.391 13.599
Unusual Expense (Income) 0 0 0.838
Operating Income -17.058 -7.854 2.372 -11.251 -4.747
Interest Income (Expense), Net Non-Operating 0.975 0.22 0.685 1.606 -3.359
Other, Net 0.095 0.052 -0.013 -0.02 -0.031
Net Income Before Taxes -15.988 -7.582 3.044 -9.665 -8.137
Net Income After Taxes -16.709 -7.471 2.864 -9.665 -8.137
Net Income Before Extra. Items -16.709 -7.471 2.864 -9.665 -8.137
Net Income -16.709 -7.471 2.864 -9.665 -8.137
Total Adjustments to Net Income 0
Income Available to Common Excl. Extra. Items -16.709 -7.471 2.864 -9.665 -8.137
Income Available to Common Incl. Extra. Items -16.709 -7.471 2.864 -9.665 -8.137
Diluted Net Income -16.709 -7.471 2.864 -9.665 -8.137
Diluted Weighted Average Shares 47.13 46.472 47.282 44.18 40.242
Diluted EPS Excluding Extraordinary Items -0.35453 -0.16076 0.06057 -0.21876 -0.2022
Diluted Normalized EPS -0.35453 -0.16076 0.06057 -0.21876 -0.18138
Total Extraordinary Items
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 45.922 41.017 52.694 38.551 37.046
Revenue 45.922 41.017 52.694 38.551 37.046
Cost of Revenue, Total 15.981 14.497 14.445 13.318 14.192
Gross Profit 29.941 26.52 38.249 25.233 22.854
Total Operating Expense 51.883 49.194 46.609 45.339 46.128
Selling/General/Admin. Expenses, Total 30.649 29.485 26.919 26.975 27.144
Research & Development 5.253 5.212 5.245 5.046 4.792
Operating Income -5.961 -8.177 6.085 -6.788 -9.082
Interest Income (Expense), Net Non-Operating 0.946 0.694 0.54 0.237 0.128
Other, Net -0.005 -0.012 -0.003 -0.005 -0.009
Net Income Before Taxes -5.02 -7.495 6.622 -6.556 -8.963
Net Income After Taxes -5.02 -7.495 5.922 -6.577 -8.963
Net Income Before Extra. Items -5.02 -7.495 5.922 -6.577 -8.963
Net Income -5.02 -7.495 5.922 -6.577 -8.963
Income Available to Common Excl. Extra. Items -5.02 -7.495 5.922 -6.577 -8.963
Income Available to Common Incl. Extra. Items -5.02 -7.495 5.922 -6.577 -8.963
Diluted Net Income -5.02 -7.495 5.922 -6.577 -8.963
Diluted Weighted Average Shares 47.572 47.387 47.232 47.182 47.117
Diluted EPS Excluding Extraordinary Items -0.10552 -0.15817 0.12538 -0.1394 -0.19023
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.10552 -0.15817 0.12538 -0.1394 -0.19023
Total Adjustments to Net Income
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 186.866 158.462 123.56 111.655 112.783
Cash and Short Term Investments 119.538 103.398 75.807 69.718 82.924
Cash & Equivalents 51.067 68.33 33.62 26.889 18.286
Total Receivables, Net 46.539 37.437 34.504 32.168 23.454
Accounts Receivable - Trade, Net 46.539 37.437 34.504 32.168 23.454
Total Inventory 15.986 13.381 9.356 6.816 3.558
Other Current Assets, Total 4.803 4.246 3.893 2.953 2.847
Total Assets 273.003 243.705 205.608 153.238 118.689
Property/Plant/Equipment, Total - Net 57.372 59.028 57.738 32.247 5.906
Property/Plant/Equipment, Total - Gross 75.674 73.35 69.124 41.467 13.411
Accumulated Depreciation, Total -18.302 -14.322 -11.386 -9.22 -7.505
Intangibles, Net 7.5
Total Current Liabilities 37.463 26.052 22.483 19.795 14.792
Accounts Payable 16.93 9.016 6.755 6.345 7.108
Accrued Expenses 20.492 16.995 15.687 13.409 6.93
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0.041 0.041 0.041 0.041 0
Other Current Liabilities, Total 0.754
Total Liabilities 80.731 73.243 71.348 42.147 16.458
Total Long Term Debt 0 0.044 0.076 0.11 0
Long Term Debt 0
Other Liabilities, Total 43.268 47.147 48.789 22.242 1.666
Total Equity 192.272 170.462 134.26 111.091 102.231
Preferred Stock - Non Redeemable, Net
Common Stock 593.245 553.902 510.061 489.749 471.18
Retained Earnings (Accumulated Deficit) -399.995 -383.286 -375.815 -378.679 -368.91
Treasury Stock - Common
Total Liabilities & Shareholders’ Equity 273.003 243.705 205.608 153.238 118.689
Total Common Shares Outstanding 47.253 46.88 45.804 44.864 43.578
Total Preferred Shares Outstanding
Short Term Investments 68.471 35.068 42.187 42.829 64.638
Other Equity, Total -0.978 -0.154 0.014 0.021 -0.039
Long Term Investments 19.962 25.687 24.099 9.247
Other Long Term Assets, Total 1.303 0.528 0.211 0.089
Capital Lease Obligations 0 0.044 0.076 0.11
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 186.211 182.871 177.545 186.866 166.375
Cash and Short Term Investments 105.343 97.831 119.276 119.538 110.94
Cash & Equivalents 60.473 43.023 61.834 51.067 65.216
Short Term Investments 44.87 54.808 57.442 68.471 45.724
Total Receivables, Net 39.729 38.319 38.359 46.539 34.296
Accounts Receivable - Trade, Net 39.729 38.319 38.359 46.539 34.296
Total Inventory 12.621 13.883 15.37 15.986 16.729
Other Current Assets, Total 28.518 32.838 4.54 4.803 4.41
Total Assets 318.125 310.711 265.096 273.003 248.017
Property/Plant/Equipment, Total - Net 103.51 98.471 59.048 57.372 58.546
Property/Plant/Equipment, Total - Gross 124.724 118.687 78.25 75.674 75.81
Accumulated Depreciation, Total -21.214 -20.216 -19.202 -18.302 -17.264
Long Term Investments 20.231 20.985 19.91 19.962 21.739
Other Long Term Assets, Total 1.142 1.196 1.249 1.303 1.357
Total Current Liabilities 35.946 35.611 28.753 37.463 27.004
Accounts Payable 15.051 14.401 11.125 16.93 8.113
Accrued Expenses 20.895 21.189 17.608 20.492 18.85
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 0.021 0.02 0.041 0.041
Total Liabilities 113.745 111.783 71.118 80.731 70.18
Total Long Term Debt 0 0 0 0 0
Capital Lease Obligations 0 0
Other Liabilities, Total 77.799 76.172 42.365 43.268 43.176
Total Equity 204.38 198.928 193.978 192.272 177.837
Common Stock 621.013 612.059 602.104 593.245 584.9
Retained Earnings (Accumulated Deficit) -416.17 -412.51 -407.49 -399.995 -405.917
Other Equity, Total -0.463 -0.621 -0.636 -0.978 -1.146
Total Liabilities & Shareholders’ Equity 318.125 310.711 265.096 273.003 248.017
Total Common Shares Outstanding 47.684 47.616 47.507 47.253 47.201
Other Current Liabilities, Total
Intangibles, Net 7.031 7.188 7.344 7.5
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -16.709 -7.471 2.864 -9.665 -8.137
Cash From Operating Activities 17.687 29.04 17.572 -7.183 -0.412
Cash From Operating Activities 3.981 2.965 2.383 1.744 1.426
Non-Cash Items 41.624 39.7 18.699 15.398 10.084
Cash Interest Paid 0.109 0.004 0.006 0 2.23
Changes in Working Capital -11.209 -6.154 -6.374 -14.66 -3.785
Cash From Investing Activities -36.206 -3.501 -17.16 10.615 -67.027
Capital Expenditures -7.596 -7.915 -2.626 -2.616 -2.678
Other Investing Cash Flow Items, Total -28.61 4.414 -14.534 13.231 -64.349
Cash From Financing Activities 1.045 9.171 6.441 5.26 58.863
Financing Cash Flow Items -2.607 -2.013 -0.191 -0.026 -0.71
Issuance (Retirement) of Stock, Net 3.652 11.184 6.632 5.286 77.105
Issuance (Retirement) of Debt, Net 0 0 -17.532
Foreign Exchange Effects
Net Change in Cash -17.474 34.71 6.853 8.692 -8.576
Cash Taxes Paid 0 0.379 0 0
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -7.495 -16.709 -22.631 -16.054 -7.091
Cash From Operating Activities 7.86 17.687 10.712 6.611 3.468
Cash From Operating Activities 1.158 3.981 2.942 1.928 0.873
Non-Cash Items 9.619 41.624 32.925 22.812 10.805
Cash Interest Paid 0
Changes in Working Capital 4.578 -11.209 -2.524 -2.075 -1.119
Cash From Investing Activities 2.8 -36.206 -14.477 -13.666 -10.669
Capital Expenditures -8.913 -7.596 -6.471 -5.062 -3.081
Other Investing Cash Flow Items, Total 11.713 -28.61 -8.006 -8.604 -7.588
Cash From Financing Activities 0.107 1.045 0.44 0.752 0.503
Financing Cash Flow Items -2.118 -2.607 -2.6 -1.459 -0.962
Issuance (Retirement) of Stock, Net 2.225 3.652 3.04 2.211 1.465
Net Change in Cash 10.767 -17.474 -3.325 -6.303 -6.698
Issuance (Retirement) of Debt, Net 0

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Vericel Corp Ord Company profile

About Vericel Corp

Vericel Corporation is a commercial-stage biopharmaceutical company. The Company specializes in cell therapies and specialty biologics for the sports medicine and severe burn care. It operates in one reportable segment, the research, product development, manufacture, and distribution of cellular therapies for use in the treatment of specific diseases. It markets two autologous cell therapy products in the United States, which includes MACI (autologous cultured chondrocytes on porcine collagen membrane) and Epicel (cultured epidermal autografts). The MACI is an autologous cellularized scaffold product indicated for the repair of symptomatic, single, or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults. The Epicel is a permanent skin replacement humanitarian use device (HUD) for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns comprising greater than or equal to 30% of total body surface area (TBSA).

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Vericel Corp revenues increased 26% to $156.2M. Net loss totaled $7.5M vs. income of $2.9M. Revenues reflect MACI segment increase of 18% to $111.6M, Epicel segment increase of 51% to $41.5M. Net loss reflects Stock-based Compensation in SGA increase from $10M to $26.5M (expense), Other Selling , General Expense increase of 21% to $71.1M (expense).

Equity composition

Common Stock no Par, 3/11, 62.5M auth., 38,618,037 issd. Insiders control approx. 0.63%. IPO: 2/97, 3M shares @ $7 byCowen & Company. 02/10 1-for-8 reverse split. 10/13, 1-for-20 Reverse Stock split.

Industry: Biopharmaceuticals

64 Sidney St
CAMBRIDGE
MASSACHUSETTS 02139-4170
US

Income Statement

  • Annual
  • Quarterly

News

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024

How escalating geopolitical tensions are impacting oil markets

The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

13:34, 4 April 2024

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

Higher CPI leaves traders unfazed as US equities continue to build momentum

The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.

12:42, 15 March 2024

People also watch

Gold

2,344.52 Price
-1.190% 1D Chg, %
Long position overnight fee -0.0193%
Short position overnight fee 0.0110%
Overnight fee time 21:00 (UTC)
Spread 0.50

BTC/USD

64,665.40 Price
+4.180% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

XRP/USD

0.50 Price
+14.340% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

US100

18,006.40 Price
-1.660% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 7.0

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading